The INNOTEST β-AMYLOID(1-42) is a solid-phase enzyme immunoassay for the quantitative determination of β-amyloid(1-42) in human cerebrospinal fluid (CSF).
The combined use of CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.1-6
CE marked
Details
Features & Benefits
User-friendly enzyme immunoassay, standard technology
Generic and color-coded components
Easily automated on microplate processor (generic components)
Ready-to-use Calibrators reduce inter and intra run variation
Run Validation Controls for assay run validation
Limit of Detection: 65 pg/mL
Calibrator range: 62,5 to 4000 pg/mL
* For research use only. Not for use in diagnostic procedures.